Figure 1From: Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases Validation of the antibodies used for application in RPMA. 30–40 μg of protein derived from human muscle (M) were fractionated on SDS-PAGE gels (see Coomasie blue stained track on top-left), blotted against the indicated antibodies and processed for western blotting. Only antibodies that recognize a single protein band of the expected molecular mass were used in the study. The migration of molecular mass markers is indicated to the left.Back to article page